The hepatocyte growth factor (HGF) is a ligand for Met, a known proto-oncogene receptor tyrosine kinase, suggesting [20,21] that this functional link between hepsin and the HGF/Met pathway may be related to tumor progression. Here, MET is linked to neoplasm.